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a b s t r a c t
The bones of the vertebrate face develop from transient embryonic branchial arches that are populated
by cranial neural crest cells. We have characterized a mouse mutant for the Forkhead family
transcription factor Foxi3, which is expressed in branchial ectoderm and endoderm. Foxi3 mutant mice
are not viable and display severe branchial arch-derived facial skeleton defects, including absence of all
but the most distal tip of the mandible and complete absence of the inner, middle and external ear
structures. Although cranial neural crest cells of Foxi3 mutants are able to migrate, populate the
branchial arches, and display some elements of correct proximo-distal patterning, they succumb to
apoptosis from embryonic day 9.75 onwards. We show this cell death correlates with a delay in
expression of Fgf8 in branchial arch ectoderm and a failure of neural crest cells in the arches to express
FGF-responsive genes. Zebraﬁsh foxi1 is also expressed in branchial arch ectoderm and endoderm, and
morpholino knock-down of foxi1 also causes apoptosis of neural crest in the branchial arches. We show
that heat shock induction of fgf3 in zebraﬁsh arch tissue can rescue cell death in foxi1 morphants. Our
results suggest that Foxi3 may play a role in the establishment of signaling centers in the branchial
arches that are required for neural crest survival, patterning and the subsequent development of
branchial arch derivatives.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Skeletal elements of the middle ear and jaw are derived from
the most anterior of ﬁve pairs of branchial arches (BA) that
develop on the ventral side of the embryo at the level of the
hindbrain (reviewed in Noden and Trainor, 2005; Szabo-Rogers et
al., 2010). Initially, each arch comprises an ectodermal surface, a
core of mesoderm, and an endodermal lining. As arch outgrowth
progresses, cranial neural crest cells migrate laterally and ventrally
from the hindbrain and posterior midbrain to populate the arch
mesenchyme, eventually forming the bulk of the mesenchyme
(Lumsden et al., 1991; Schilling and Kimmel, 1994; Serbedzija et
al., 1992). Bones and cartilage of the lower face are mainly derived
from these neural crest cells, whose descendants form the mand-
ible, maxilla, tympanic ring, and bones of the middle ear, among
other structures. Perturbations in proliferation, migration, pattern-
ing, and differentiation of cranial neural crest cells can therefore
lead to malformations of craniofacial skeletal structures (Passos-
Bueno et al., 2009; Szabo-Rogers et al., 2010).
As the branchial arches expand ventrally, their anterior and
posterior borders are deﬁned by a series of contact points between
pharyngeal ectoderm and underlying pharyngeal endoderm,
which form morphological barriers called pharyngeal pouches.
The pouches isolate populations of mesenchyme in each arch, and
are also points of communication between ectoderm and endo-
derm (Couly et al., 2002). They are sources of signaling molecules
that promote neural crest cell survival and contribute to the
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establishment of proximal–distal and anterior–posterior axes
within each arch (Brito et al., 2006; Couly et al., 2002; David et
al., 2002).
We have previously identiﬁed a transcription factor, Forkhead
Box i3 (Foxi3), that is expressed in the pharyngeal region of mouse
embryos in a segmented pattern between the branchial arches
(Ohyama and Groves, 2004). Foxi3 is one of three Foxi transcrip-
tion factors present in the mouse genome, all of which are closely
related to the zebraﬁsh foxi1 transcription factor. Mouse Foxi1
expression is limited to the dorsal otic vesicle, and Foxi1 mutant
mice exhibit only balance defects (Hulander et al., 1998, 2003).
However, zebraﬁsh foxi1 is expressed in the pharyngeal epithelium
during arch development (Solomon et al., 2003b). A zebraﬁsh foxi1
mutant, hearsay, lacks an otic vesicle and presents severe defects
in skeletal structures of the face that develop from the anterior
arches (Nissen et al., 2003; Solomon et al., 2003a). We have
generated a mouse Foxi3 mutant, and found a facial skeleton
phenotype that is similar to zebraﬁsh hearsay mutants. Foxi3
mutants lack much of the lower jaw and other branchial arch
derivatives, such as the entire middle and external ear apparatus.
Here, we characterize the mechanism underlying the branchial
arch defects of Foxi3 mutants. We show that cranial neural crest
cells emigrate normally from the brain of Foxi3 mutants, but then
undergo apoptosis as they populate the branchial arches. Since
neural crest cells do not express Foxi3, this suggests that Foxi3may
regulate the expression of trophic or survival factors in arch
ectoderm or endoderm. We show that the activity of Foxi3 in
pharyngeal epithelia is required for early expression of Fgf8 in arch
ectoderm. We also show a conservation of this pathway in
zebraﬁsh; here, fgf3 is expressed in branchial arch ectoderm and
requires the expression of foxi1. We show that ectopic expression
of fgf3 in pharyngeal ectoderm can reduce neural crest cell death
in zebraﬁsh foxi1 morphants. We propose that Foxi1 and 3
expression is required for normal pharyngeal pouch morphology
in zebraﬁsh and mouse respectively, that it establishes signaling
centers in the developing branchial arches necessary for crest
survival, and that the craniofacial phenotype seen in Foxi3mutants
is due to reduced FGF8 signaling in the pharyngeal region.
Materials and methods
Generation of Foxi3 mutant mice
The targeting vector for the mouse Foxi3-ﬂoxed-neo allele was
constructed using BAC recombineering (Warming et al., 2005).
Brieﬂy, an approximately 11 kb genomic DNA fragment containing
exon 2 of mouse Foxi3 was retrieved from a BAC clone bMQ 285H11
of 129Sv BAC genomic library obtained from the Wellcome Trust
Sanger Institute (Adams et al., 2005) Using recombineering, a loxP
site was inserted upstream of exon 2, and an Frt–PGKNeo–Frt–LoxP
sequence as inserted downstream of exon 2 (Fig. 2A) (Meyers et al.,
1998). Electroporation of the targeting vector into ES cells, screening
of the targeted ES cells and blastocyst injection were performed by
the transgenic core facility at the Norris Cancer Center of the
University of Southern California. Germline Foxi3-ﬂoxed-neo founder
mice were identiﬁed and conﬁrmed by genomic Southern blotting
to detect the extra EcoRV and NheI sites introduced by the Frt–
PGKNeo–Frt–LoxP sequence (Fig. 2B). The Foxi3-del allele used in this
study was generated by crossing the Foxi3-ﬂoxed-neo allele with
CMV-Cre line (JAX Mice, stock #003465).
Mouse genotyping
The Foxi3 deletion allele (Foxi3-del) was maintained by breed-
ing heterozygous mice. Primers used to genotype embryos were
f3G1 (50-GGC CTT GTC TCA ACC AAC AG-30), f3G2 (50-GTT TCC TGT
ATC CCT GGC TG-30) and f3G3 (50-CTT GGA ATG GGT TGA CTG
AG-30). f3G1 and f3G2 produce a 350 bp band corresponding to the
wild-type allele and f3G1 and f3G3 yield a 600 bp band corre-
sponding to the Foxi3-del allele.
Whole mount DAPI imaging
Embryos were ﬁxed, washed in PBS with 1% Triton X-100,
incubated for 5 min in DAPI solution, and washed in PBS with 0.1%
Tween-20. Embryos were mounted in PBS in a depression slide
and photographed on a confocal microscope using the methods
described by Sandell et al. (2012).
Skeletal staining
Mouse embryos were deeply anesthetized in PBS on ice and
decapitated. Heads were scalded in 70 1C water and skin was
removed. Skulls were stained with Alizarin Red and Alcian Blue as
described (Ovchinnikov, 2009). Brieﬂy, skin was removed from the
embryos and ﬁxed in 95% ethanol, the heads were defatted
overnight in acetone, and cartilage was stained overnight in
0.015% Alcian Blue in 80% ethanol:20% acetic acid. The heads were
rinsed in 70% ethanol, cleared in 2% potassium hydroxide and
counter-stained with 0.005% Alizarin Red in 1% potassium hydro-
xide. After staining, the embryos were cleared in 1% potassium
hydroxide followed by stabilization and storage in a 1:1 solution of
glycerol and ethanol.
Probe synthesis and in situ hybridization
Digoxygenin-labeled, cRNA probes were synthesized for whole
mount in situ hybridization as described (Stern, 1998) using
plasmid clones from the following sources: Dlx2 ( John Ruben-
stein), Dlx5 (Jin Xian Liu), Sox10 (Michael Wegner), Erm (Annette
Neubuser), Fgf8 and Spry2 (Gail Martin), Dlx3 (Maria Morasso),
Pax9 (Rudi Balling), Gsc (Richard Behringer), Lhx7 (Maria Grigor-
iou), and Pitx1 (Dan Bernard). The Foxi3 probe was generated by
our lab and previously described (Ohyama and Groves, 2004).
Whole mount in situ hybridization was performed as recently
described (Khatri and Groves, 2013). After in situ hybridization,
stained embryos were equilibrated in 15% sucrose in PBS and
embedded in 7.5% gelatin with 15% sucrose in PBS for sectioning.
Immunohistochemistry
Embryos were ﬁxed and embedded in gelatin (7.5% gelatin and
15% sucrose in PBS). 14 μm thick sections were collected on
Superfrost Plus slides. For cleaved caspase-3 detection, cleaved
caspase-3 antibody (AF835, R&D Systems) was diluted 1:200 in
blocking buffer (PBST with 0.1% Triton X-100 and 10% goat serum).
Secondary antibody (AlexaFluor 488 goat anti-rabbit, Invitrogen)
was diluted 1:1000 in blocking buffer. For AP2α detection, slides
were boiled in 10 mM citric acid for 10 min prior to antibody
application. The 3B5 AP2α monoclonal antibody developed by
Trevor Williams was obtained from the Developmental Studies
Hybridoma Bank developed under the auspices of the NICHD and
maintained by the University of Iowa, Department of Biology, Iowa
City, IA 52242. AP2α antibody was diluted 1:100 in blocking buffer.
Slides were incubated for 15 min at room temperature in 0.012%
hydrogen peroxide prior to secondary antibody application. Staining
was detected with biotinylated secondary antibody (Mouse Vectas-
tain ABC kit) in conjunction with PerkinElmer TSA Plus Cyanine-3
System. All slides were mounted in Fluoromount G (Southern
Biotech). For dephosphorylated-ERK, whole embryos were incu-
bated with p44/p42 MAPK rabbit polyclonal (Cell Signaling #9101)
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diluted 1:350 in PBS with 0.02% Tween-20 and 5% goat serum.
dpERK was detected with the Vectastain HRP ABC kit with nickel
intensiﬁcation. Embryos were then embedded in gelatin and
sectioned at 14 μm.
Quantiﬁcation of apoptotic cells in mouse
Cells located within BA1 at any point ventral to the ﬂoor plate
of the neural tube that were stained with the cleaved caspase-3
antibody were counted in 14 μm sections from 6 wild type and 5
Foxi3 mutant embryos at 25 somites of development. The average
number of apoptotic cells per section in each embryo was
calculated and these values were used to determine the average
number of apoptotic cells and the standard error in Foxi3 mutants
and wild types. Statistical signiﬁcance was determined with a two-
tailed t-test assuming unequal variance.
Zebraﬁsh experiments
Wild type zebraﬁsh embryos were derived from AB line
(Eugene, OR). In this study transgenic lines Tg(hsp70:fgf8a)x17
(Millimaki et al., 2010) and Tg(hsp70:fgf3)x27 (Sweet et al., 2011),
referred to hereafter as hsfgf8 and hsfgf3, were used. Except where
noted, embryos were maintained at 28.5 1C in ﬁsh water (aqueous
solution of.008% Instant Ocean salts) containing methylene blue
and PTU (1-phenyl 2-thiourea, 0.3 mg/ml, Sigma) to block melanin
formation. For global mis-expression of hsfgf3, embryos were
incubated at 37 1C for 30 min and then transferred to 33 1C to
maintain weak transgene activity for an extended period. For
global mis-expression of hsfgf8, embryos were incubated at
35 1C for 6 h. For morpholino injections approximately 5 ng foxi1
morpholino oligomer was injected per embryo at 1-cell stage. The
sequence of foxi1-MO has been published previously (Solomon
et al., 2003a). Whole mount in situ hybridization and cryosection-
ing were performed as described previously (Phillips et al., 2001;
Vemaraju et al., 2012). For cell death analysis, embryos were
dechorionated and incubated in ﬁsh water containing 2 μg/ml
acridine orange for 1 h. The embryos were then washed twice with
ﬁsh water prior to observation. Laser activation of hs:fgf3 was
performed using a MicroPoint system with a NL100 nitrogen laser
(Stanford Research Systems). Laser power was partially attenuated
to avoid cell ablation and applied with a 20 objective in a series
of 15–18 pulses per region.
Quantiﬁcation of apoptotic cells in zebraﬁsh
Acridine orange-positive cells were counted in the region
between the midbrain hindbrain border and the ﬁrst somite, and
between the pharyngeal endoderm and the roof of the otic vesicle.
11–18 embryos were analyzed for cell death quantiﬁcation in most
experiments, but 7 foxi1 morphants were analyzed following a
37 1C 30 min heat-shock and 9 embryos were quantiﬁed for focal
hsfgf3 rescue experiments. Both wild type and foxi1 morphant
embryos showed generalized elevation of cell death during laser
activation (i.e. on both the irradiated and non-irradiated sides) due
to prolonged exposure to tricaine anesthetic.
Results
Foxi3 is expressed in pharyngeal endoderm and ectoderm
During branchial arch development, dorsal-ventral, proximal-
distal, and oral-aboral domains of ectoderm are deﬁned by unique
gene expression patterns (Danesh et al., 2009; Liu et al., 2005;
Maemura et al., 1996). We extended our previous work on the
expression pattern of Foxi3 expression (Ohyama and Groves, 2004)
to gain further insights into its developmental function. Prior to
branchial arch outgrowth, Foxi3 is expressed broadly in the
pharyngeal region in both ectoderm and endoderm at the six
somite stage (6ss; Fig. 1). As the ﬁrst branchial arch (BA1) becomes
morphologically distinct, Foxi3 expression is down-regulated in
expanding arch ectoderm and its expression domain bifurcates
into two distinct patches of tissue anterior and posterior to the
arch itself. By the 15ss, Foxi3 expression is restricted to epithelium
between the two morphologically identiﬁable arches present at
this stage, BA1 and BA2. At this point, three Foxi3 expression
domains are observable: anterior to BA1 at low levels, in the cleft
between BA1 and BA2, and posterior to BA2. Foxi3 continues to be
expressed in the ectoderm and in the endoderm underlying these
three domains (Fig. 1). As the remaining branchial arches develop,
Foxi3 expression divides further and is expressed in the endoderm
of each pharyngeal pouch as well as the overlying cleft ectoderm,
with stronger expression around posterior, later-developing arches
and the expression in anterior arches gradually becoming fainter
(Fig. 1). It is important to note that Foxi3 is expressed neither in
branchial arch mesoderm nor in the cranial neural crest cells that
populate arch mesenchyme (Fig. 1, section).
Foxi3 mutant mice have aberrant pharyngeal morphology and severe
defects in arch-derived skeletal structures
We generated Foxi3 mutant mice by targeting the second of
two exons coding for Foxi3 using a conditional strategy (Fig. 2). To
determine the function of Foxi3 in pharyngeal development, we
examined Foxi3 mutant mice at various stages in embryonic
development, beginning at embryonic day 8.0 (E8.0) through birth
(P0). Foxi3 mutants are not viable, with embryos dying across a
range of ages beginning around E9.5. Some Foxi3 mutant embryos
are born, but die immediately after birth. These pups are readily
identiﬁable by their lack of mouth, with a continuous ectodermal
covering over the lower half of the face, and by the absence of
external ear pinnae (Fig. 3). Although whisker follicles are found
on the snouts of Foxi3 mutant pups, whiskers are absent
(Supplementary Fig. 1), consistent with the expression of Foxi3
in hair follicles (Drogemuller et al., 2008). Dead pups have been
noted in cages while the dam is giving birth to the remainder of
the litter. As wild-type and heterozygous pups do not yet display
milk spots in these litters, it appears unlikely that the mutants die
due to starvation. More probably the disrupted development of
their lower faces renders mutants unable to breathe.
The apparent lack of mouths and the smaller size of their faces
suggest some skeletal alterations in Foxi3 mutants. In order to
carefully catalog changes in bone and cartilage structures resulting
from loss of FOXI3, we stained the heads of mutant and wild type
mouse embryos with Alcian Blue and Alizarin Red to reveal
cartilage and bone respectively (Fig. 3). Skeletal staining of the
heads of E18.5 Foxi3 mutant embryos reveals a number of severe
defects in bone and cartilage development. In Foxi3 mutants, only
a small anterior portion of the mandible develops and is fused to the
distal end of maxilla. The maxilla itself is also malformed, as is the
squamosal portion of the temporal bone. The jugal is absent and the
palatines are reduced in size. Additionally, there is no sign of the
tympanic ring or incus, malleus, or stapes of the middle ear, and the
entire inner ear is absent (Fig. 3). A full description of the inner ear
phenotype of Foxi3 mutant mice will be published separately.
Although the mandible is almost entirely absent, bone and cartilage
staining at E16.5 reveals that at least some elements of Meckel's
cartilage are present in Foxi3 mutant embryos. However, it is mis-
shapen, curving downward and away from the midline (Fig. 3). To
document any other roles of Foxi3 in skeletal development, we also
examined E18.5 whole embryos. We observed no gross
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morphological defects in any skeletal elements below the neck in
Foxi3mutants, although more than half of embryos that develop to
E18.5 displayed a wide gap between the frontal bones of the skull
(data not shown).
Interestingly, the affected skeletal structures we observed in
Foxi3 mutants are derivatives of the cranial neural crest cells that
populate BA1 and 2, cell populations that do not express Foxi3
(Fig. 1). We therefore examined embryos at earlier embryonic
stages to assess whether absence of FOXI3 from ectoderm and
endoderm resulted in a developmental defect that might even-
tually lead to loss of neural crest-derived skeletal structures.
Indeed, we found the anterior pharyngeal region to be morpho-
logically disrupted early in development in Foxi3 mutants. At 15ss,
when a distinct BA1 is readily apparent in wild-type mouse
embryos, coronal sections through the pharyngeal region of
Foxi3 mutants show a failure to individuate distinct arches. The
pharyngeal pouches that segregate mesenchyme of one arch from
the next are not present; there are no contact points between
Fig. 2. Generation of Foxi3 mutant mice. (A) Diagram of the mouse Foxi3 locus, composed of two coding exons. A targeting vector was generated containing a loxP site
upstream of exon 2 and an Frt–PGKNeo–Frt–LoxP sequence downstream of exon 2. (B) The successfully targeted allele introduced an extra NheI and EcoRV site into the locus
that could be detected by Southern blotting with 50 and 30 probes. Crossing successfully targeted offspring with CMV-Cre mice recombined the loxP sites to generate the
Foxi3-del allele.
Fig. 1. Foxi3 is expressed in pharyngeal ectoderm and endoderm. Prior to branchial arch outgrowth, Foxi3 is expressed broadly in the pharyngeal region in both ectoderm
and endoderm. As arch development progresses, Foxi3 expression is reﬁned to the clefts between the arches (arrowheads). Foxi3 is expressed in both ectoderm and
endoderm, but is not expressed in the mesoderm or neural crest cells that make up the mesenchyme of the arches. A1 – branchial arch 1, A2 – branchial arch 2,
P1 – pharyngeal pouch 1, P2 – pharyngeal pouch 2, and ss – somite stage of development. Scale bars are 100 μm.
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pharyngeal endoderm and ectoderm and all arch mesenchymes
are continuous (Fig. 4A). This morphological defect is particularly
striking a day later in development in 25ss whole-mount embryos,
where well-deﬁned arches in wild-type embryos are replaced by a
smooth expanse of ectoderm in Foxi3 mutants (Fig. 4A). Notably,
the transcription factor Pax9, normally expressed most strongly in
the pharyngeal pouches during early arch outgrowth, is expressed
continuously throughout the pharyngeal endoderm of 15 somite
Foxi3 mutants (Fig. 4B) (Neubuser et al., 1995). In a pattern highly
reminiscent of endodermal Foxi3 expression, Pax 9 expression
diminishes from the pouches in a gradient, with lower expression
in anterior pouches than in posterior pouches by 25 somites. In
Foxi3 mutants at 25ss as in 15ss, expression is continuous
throughout the endoderm and persists in the anterior pharyngeal
region (Fig. 4B). This altered pattern suggests a failure of endo-
derm to establish pouch- and arch lining-speciﬁc domains in the
absence of Foxi3. However, in spite of the failure of pharyngeal
pouches to form morphological barriers between arches in Foxi3
mutants, we observed that anterior Hox-negative and posterior
Hoxb2-positive populations of neural crest cells in the arches do
not intermingle, suggesting that initially neural crest identity may
not be affected in Foxi3 mutants (data not shown).
Neural crest cells in Foxi3 mutants migrate to the arches and begin
to differentiate, but then die
Although Foxi3 is not expressed in migrating neural crest cells,
these cells must migrate past Foxi3-expressing ectoderm and
endoderm in order to enter the arches. To address the possibilities
that neural crest cells are not entering the branchial arches, or are
unable to differentiate in the altered pharyngeal environment of
Foxi3 mutants, we examined mutant and wild type embryos for
expression of migratory and post-migratory neural crest cell
markers. We observed Sox10-expressing cells exiting the neural
tube at 15ss, suggesting that cranial neural crest cell formation and
early emigration from the midbrain and hindbrain are unaffected.
Although the migration pattern of Sox10-positive cells is slightly
altered in Foxi3 mutants due to the absence of the otic placode and
pharyngeal pouches, we saw no obvious difference in the numbers
of cranial neural crest cells entering the pharyngeal region
(Fig. 5A).
During early arch development, post-migratory neural crest
cells establish a proximal-distal axis in each arch via a nested
pattern of expression of six Dlx transcription factors (Fig. 5A) (Qiu
et al., 1997). To ascertain whether neural crest cells are able to
initiate a differentiation program in Foxi3 mutant arches, we
examined 18ss embryos for expression of Dlx2, 3 and 5. In spite
of the failure of Foxi3 mutants to form distinct arches, neural crest
cells do qualitatively adopt the typical nested Dlx pattern. We saw
no signiﬁcant differences in the extent of Dlx2, which is expressed
throughout the proximo-distal extent of the ﬁrst arch (Fig. 5B).
However, the numbers of cells expressing the distal marker Dlx3
are noticeably reduced in the mesenchyme at the level of pre-
sumptive BA1 (Fig. 5B). The size and intensity of the intermediate
to distal Dlx5-expressing population are likewise reduced, but to a
lesser extent than Dlx3.
Fig. 3. Neural crest derived bones of the head are malformed or absent in Foxi3 mutants. In Foxi3 mutants at E16.5, Meckel's cartilage (mc) is misshapen and a distinct
mandible is absent. At E18.5 the full range of Foxi3 mutant skeletal defects are apparent. A truncated mandible (m*) is fused to the maxilla (mx*). The maxilla is malformed
and the jugal (j) is absent (missing structures indicated by arrowheads), and the squamosal bone (sq*) and palatines (p*) are misshapen. The middle and inner ears are
absent, indicated by an asterisk (*). Removed from the maxilla, the fused portion of mandible is small, truncated, and asymmetrical. Foxi3 mutant pups lack an external ear
and the lower half of the face is covered in continuous ectoderm. In a magniﬁed view of the Foxi3 mutant ear all ear structures are absent, including tympanic ring (t),
malleus (ma), incus (i), and stapes (s). Basisphenoid – bs; premaxilla – pmx; vomer – v.
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Although neural crest cells migrate into the pharyngeal region
of Foxi3 mutants, the structures derived from many of those cells
are absent, leading to the question of what becomes of the BA1
mesenchyme. An obvious possibility is apoptosis of neural crest
cells. We stained transverse sections through presumptive BA1 in
Foxi3 mutants for activated caspase-3, a marker of apoptosis, and
for the transcription factor AP2α, expressed in neural crest cells
and pharyngeal ectoderm but not in pharyngeal mesoderm
(Brewer et al., 2002). Prior to 25ss we saw no increase in apoptosis
among cells in presumptive BA1 of Foxi3 mutants (data not
shown); however, beginning at 25ss a population of mesenchymal
cells near the ventral edge of the pharyngeal ectoderm contains
activated caspase-3, indicating an abnormal increase in cell death
in cells corresponding to the distal population of cells in BA1
(Fig. 6A). The difference in apoptotic cells is signiﬁcant, with wild
type embryo sections containing an average of 5.8 dying cells
per section versus 14.7 cells in Foxi3 mutants (Fig. 6B). Dying cells
are concentrated in the posterior region of presumptive BA1.
Adjacent sections from the same Foxi3 mutant embryos stained
with AP2α suggest that these dying cells are neural crest rather
than mesoderm (Fig. 6A).
Fgf8 expression in pharyngeal ectoderm is delayed in Foxi3 mutants
Foxi3 is a transcription factor expressed in epithelial cells, but
the bulk of the affected structures in the arch region of Foxi3
mutants is neural crest-derived. It is therefore likely that a
signaling molecule that is expressed in Foxi3-positive cells com-
municates from pharyngeal epithelium to neural crest mesench-
yme and that expression of such a signaling factor might be
altered in Foxi3 mutants. An excellent candidate for this signaling
factor is Fibroblast growth factor 8 (Fgf8). Fgf8 has a well-documented
role in cell survival in the pharyngeal region of amniotes (Abu-Issa
et al., 2002; Tucker et al., 1999). The requirement for FGF signaling to
Fig. 4. Foxi3 mutant mice do not form pharyngeal pouches. (A) Coronal sections through 12ss embryos stained with DAPI reveal absence of a distinct pharyngeal pouch 1
(p1) between the ﬁrst two pharyngeal arches (a1 and a2) in the Foxi3 mutant (asterisk). At 25 somites, confocal imaging of DAPI-stained embryos shows that Foxi3 mutant
embryos have clearly failed to form distinct arches (asterisk). (B) Whole mount embryos at 15 somites and 25 somites show less distinct patterns of Pax9 expression around
the presumptive pharyngeal pouches. Coronal sections through these embryos reveal continuous expression of Pax9 along the entire extent of pharyngeal endoderm at both
ages in Foxi3 mutants, whereas Pax9 is restricted to pouches in wild type embryos.
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support cranial neural crest cell survival and branchial arch devel-
opment is conserved from ﬁsh to mammals, and loss of pharyngeal
Fgfs leads to missing craniofacial skeletal structures in vertebrates
(Crump et al., 2004; Trumpp et al., 1999). Foxi3 and Fgf8 are
expressed in similar patterns in the pharyngeal region, and Foxi3
mutants and Fgf8 branchial ectoderm-conditional knockouts have
similar phenotypes, in particular, a signiﬁcantly reduced mandible
and concomitant apoptosis of cranial neural crest cells in the ﬁrst
arch (Abu-Issa et al., 2002; Crossley and Martin, 1995; Trumpp et
al., 1999). In Foxi3 mutants, Fgf8 expression in the pharyngeal
ectoderm is delayed until well after BA1 normally develops. At
15ss, Fgf8 is absent from pharyngeal ectoderm of Foxi3 mutants
while strongly expressed in wild-type embryos (Fig. 7A). Fgf8
expression is present but reduced in the endoderm at these stages
(Fig. 7A). Fgf8 is eventually expressed in pharyngeal ectoderm
hours later at about 22ss (Fig. 7A).
Although Fgf8 is present in the pharyngeal endoderm of Foxi3
mutants, the residual FGF8 appeared insufﬁcient to induce a
typical signaling response in arch mesenchyme. At 15ss, expres-
sion of Erm, an ETS-domain containing transcription factor
induced by FGF signaling is absent from the distal mesenchyme
of presumptive BA1 in Foxi3mutants but not in the brain (Fig. 7B).
Likewise, Foxi3 mutant mesenchyme displays reduced MAPK
signaling, as assessed by reduced presence of phosphorylated
ERK in mesenchymal cells (Fig. 7B).
To clarify the extent to which reduced and delayed FGF8
signaling from the ectoderm inﬂuences not just neural crest cell
survival, but also overall pattering in BA1, we examined expression
of additional transcription factors. Both goosecoid (Gsc) and Lhx7 in
the BA1 mesenchyme are expressed around E9.5 in response to
FGF8 (Grigoriou et al., 1998; Trumpp et al., 1999). In Foxi3mutants,
as in wild type embryos at 25ss, Gsc is expressed in the proximal
Fig. 5. Neural crest cells migrate, populate and pattern the Foxi3mutant pharyngeal region. (A) In 15 somite staged embryos, neural crest cells expressing Sox10 migrate out
of the neural tube and into the pharyngeal region, but do not divide into separate arch populations (asterisks). After entering the arches, neural crest cells establish a
proximal–distal axis through nested and combinatorial expression of Dlx transcription factors (illustration in A). (B) In 18 somite staged Foxi3 mutants, neural crest cells
adopt the nested expression pattern (A), but the population of cells expressing the intermediate and distal factors Dlx5 and Dlx3 are smaller in the mutant ﬁrst arch. Scale
bars are 100 μm.
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region of BA1 between the mandibular and maxillary prominences
(Fig. 8). Lhx7, in contrast, is expressed in two distinct domains at
25ss – at the distal tip of BA1 and at the anterior extreme of BA1
where the maxillary prominence is just beginning to expand
(Fig. 8). In Foxi3 mutants, only one domain is present in the
truncated BA1, suggesting an absence of much of the intervening
region of the arch (Fig. 8). A possible explanation for this
difference may be that Gsc expressing tissues are still present in
the absence of Foxi3, but the severely truncated arches in the
mutants have speciﬁcally lost transcriptionally unique intermedi-
ate or distal domains.
That hypothesis may be supported by evidence from transcrip-
tion factors regulated through other signaling pathways in the
arches. Pitx1 expression and Msx1 expression have been described
to be unaltered by loss of Fgf8 from the ectoderm (Liu et al., 2005;
Trumpp et al., 1999). Interestingly, the pattern of Msx1 expression
is similar to Lhx7, as is the pattern change in Foxi3 mutants, with
two BA1 Msx1 domains in the wild type embryo reduced to one
domain in the Foxi3 mutant. Although the major morphological
differences between Foxi3 mutants and wild type embryos result
in a noticeable decrease in Pitx1 expression area, the relative
location in which it is expressed is unchanged in Foxi3 mutant
arches at both 15ss and 25ss (Fig. 8). The changes seen in Foxi3
mutants are consistent with a loss of intermediate and distal arch
transcriptional domains. Of note, but beyond the scope of this
study, Pitx1 expression anterior to BA1 is reduced in Foxi3mutants
at 25ss (asterisk, Fig. 8).
Restoration of Fgf signal in zebraﬁsh foxi mutants rescues the cell
death and skeletal phenotypes
To conﬁrm that loss of ectodermal FGF signaling was respon-
sible for neural crest cell death in the arches of Foxi mutants, we
preformed a rescue experiment in zebraﬁsh. The functional
homologs of mouse Foxi3 and pharyngeal Fgf8 in zebraﬁsh are
foxi1 and fgf3 (Nissen et al., 2003; Solomon et al., 2003a).
Accordingly, zebraﬁsh foxi1 is expressed in pharyngeal ectoderm
and endoderm but is excluded from neural crest-derived phar-
yngeal arches (Solomon et al., 2003a). A previous study reported
that nascent migratory neural crest cells expressing krox20 initially
co-express foxi1 (Nissen et al., 2003). However, analysis of gene
expression under high magniﬁcation revealed that migratory
streams of neural crest expressing krox20 remain distinct from
the pharyngeal domain of foxi1, with no cells co-expressing both
markers (Fig. 9A and A0). We conﬁrmed in tissue sections that
zebraﬁsh fgf3 is expressed in pharyngeal pouch endoderm during
appropriate stages to affect pharyngeal arch morphogenesis
(Fig. 9C and C0). To test if foxi1 also regulates fgf3 expression to
promote neural crest survival, we knocked down foxi1 with
previously characterized translation-blocking morpholinos
(Solomon et al., 2003b). Pharyngeal expression of fgf3 is down-
regulated in foxi1 morphants as early as 22 h post-fertilization
(hpf), followed by a wave of apoptosis in pharyngeal arch tissue
peaking at around 26 hpf, with an average of 102.1 apoptotic cells
in the pharyngeal arches of a morphants (Fig. 10A and B, n¼7)
(Nissen et al., 2003).
To investigate the relationship between altered Fgf signaling
and elevated cell death, we injected foxi1 morpholinos into
transgenic zebraﬁsh containing heat shock-inducible transgenes
encoding fgf3 or fgf8. High-level mis-expression of either trans-
gene caused developmental defects precluding meaningful inter-
pretation. However, global low-level activation of hs:fgf3 (37 1C for
30 min) beginning at 20 hpf signiﬁcantly suppressed cell death in
foxi1morphants, reducing the average number of apoptotic cells in
the arches nearly by half to 52.7 cells per embryo (Figs. 9G and
10B, n¼20). Similarly, global activation of hs:fgf8 (35 1C for 6 h)
Fig. 6. Neural crest cells undergo apoptosis in Foxi3mutant arches. (A) Neural crest cells, stained with AP2α, undergo apoptosis, indicated by active caspase-3 in the distal tip
of Foxi3mutant arches (box 3). Some apoptosis occurs in the proximal region of wild type and Foxi3mutant arches (boxes 1 and 2). We excluded these cells from neural crest
cell death quantiﬁcation because they exist in both populations and are AP2α-negative. Higher magniﬁcation images of the regions highlighted with white boxes are shown
below. Scale bars are 100 μm. (B) The increase in apoptosis in Foxi3mutant arches is statistically signiﬁcant (p¼0.04). Foxi3mutants n¼5; wild type n¼6 embryos. Error bars
represent the standard error of the mean.
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beginning at 20 hpf also signiﬁcantly suppressed cell death in foxi1
morphants, resulting in an average of 45.3 apoptotic cells in the
arches (Figs. 9H and 10A, n¼20).
Because global activation of these transgenes might not suita-
bly mimic endodermal fgf3, we used an ablative laser set on low
power to locally activate hs:fgf3 in the pharyngeal region begin-
ning at 20 hpf (see inset cartoon in Fig. 9D0). Subsequent assess-
ment of fgf3 expression conﬁrmed the transgene remained active
on the laser-irradiated side through at least at 22 hpf (Fig. 9D and D0).
Moreover, all specimens showed signiﬁcant suppression of cell
death on the laser-irradiated side, whereas cell death was not
rescued on the non-irradiated side: an average of 76.6 apoptotic
cells on the irradiated side, versus 165.2 on the non-irradiated
side. (Figs. 9I and I0, and 10C, n¼8). In contrast, laser-activation of
hs:fgf3 after 22 hpf did not rescue the cell death phenotype in foxi1
morphants (n¼3, data not shown), indicating that the require-
ment for Fgf signaling is highly stage-dependent.
Discussion
The complex orchestration of cell migration, differentiation,
and death underlying the formation of the vertebrate face and jaw
is regulated by a wide range of signaling molecules whose
expression is established by many families of transcription factors
(Cobourne and Sharpe, 2003; Depew et al., 2005; Medeiros and
Crump, 2012). Subtle changes in the timing, location, or strength
of gene expression can serve as a substrate for cranial morpholo-
gical diversity in vertebrates, or alternatively lead to a wide range
of craniofacial abnormalities (Minoux and Rijli, 2010; Passos-
Bueno et al., 2009; Szabo-Rogers et al., 2010). In the present study,
we show that loss of Foxi3, a mouse Forkhead family transcription
factor, leads to severe craniofacial defects consistent with a loss of
most anterior branchial arch derivatives. We show that although
Foxi3 is expressed exclusively in branchial arch ectoderm and
endoderm, the principle defect in Foxi3 mutants is a signiﬁcant
loss of arch neural crest cells due to apoptosis. We propose that
Foxi3 indirectly promotes the survival of arch neural crest cells by
establishing the expression of Fgf8 in branchial clefts. Moreover,
we show that zebraﬁsh foxi gene regulates arch survival in a
similar fashion: loss of foxi1 from the zebraﬁsh arch region leads to
cell death that can be rescued by re-activating expression of fgf3 in
the arch region.
Foxi3 is expressed exclusively in pharyngeal ectoderm and
endoderm (Fig. 1), but neural crest cells that migrate into the
branchial arches are unable to develop into skeletal arch deriva-
tives in the absence of Foxi3. In Foxi3 mutants, neural crest cells
appear to be induced normally, exit the neural tube in expected
Fig. 7. Fgf8 expression is delayed in Foxi3 mutant pharyngeal ectoderm. The expression pattern of Fgf8 at 15 somites is similar to the Foxi3 expression pattern at the same
stage. In 15 somite staged Foxi3 mutants, Fgf8 expression is substantially reduced and is present only in pharyngeal endoderm but not pharyngeal ectoderm. Expression of
downstream transcription factor Erm is reduced in Foxi3 mutants to a few cells adjacent to the endoderm. MAPK signaling as indicated by di-phosphorylated Erk (pErk) is
detectable in many fewer mesenchymal cells in Foxi3 mutant embryo arches. The level of staining in Foxi3 mutants was similar to that seen in wild type embryos incubated
for 30 min in the MAPK inhibitor U0126 (not shown). Expression of Fgf8 partially recovers in pharyngeal ectoderm by 22 somites, but is still not expressed as broadly as in
wild type embryos of corresponding ages. Scale bars are 100 μm.
R.K. Edlund et al. / Developmental Biology 390 (2014) 1–13 9
numbers, migrate along roughly correct paths to the presumptive
branchial arches, and populate the space between pharyngeal
ectoderm and endoderm (Fig. 5). In Foxi3 mutants, the normal
eversion of pharyngeal endoderm and its apposition with phar-
yngeal ectoderm fail to occur (Fig. 4). Interestingly, one marker of
the pharyngeal pouches, Pax9, is expanded in Foxi3 mutants
throughout the endoderm. In spite of a failure in pharyngeal
pouch formation or other obvious barriers between BA1 and
BA2, Hox-negative post-migratory neural crest cells from the
midbrain and rhombomeres 1 and 2 that normally populate BA1
do not appear to mix with the Hoxb2-expressing neural crest from
more posterior rhombomeres that populates more posterior
arches. Alternatively, it is possible that mesodermal signals that
have been suggested to modulate Hox gene expression in post-
migratory crest are still present Foxi3 mutants (Trainor and
Krumlauf, 2000).
Upon arrival in the presumptive arches, neural crest cells begin
to respond to arch-speciﬁc differentiation signals and establish the
nested pattern of Dlx transcription factor expression that deﬁnes
the proximal-distal axis within the arch mesenchyme (Depew et
al., 2005). It is at this point – when neural crest cells have
completed their migration and begun differentiation – that their
development goes awry in Foxi3 mutants. Since Foxi3 is expressed
in the epithelium of the branchial clefts and pouches, it cannot
directly contribute to survival and differentiation of neural crest
cells; it must be acting through a pathway with additional
components.
One good candidate for such a survival factor is Fgf8 – it is
expressed in pharyngeal arches as crest cells invade, and condi-
tional or hypomorphic alleles of Fgf8 display crest cell death and
severe morphological defects in arch derivatives (Abu-Issa et al.,
2002; Crossley and Martin, 1995). Our data suggest that Foxi3
regulates Fgf8 expression in pharyngeal cleft ectoderm, and that
the transient loss of Fgf8 expression in Foxi3 mutants is sufﬁcient
to cause crest cell death. We do not see Fgf8 expression in the
developing arch ectoderm of Foxi3 mutants at the 15ss (approxi-
mately E8.75–E9.0). Neural crest cells at the most ventral region of
the pharyngeal tissue in Foxi3 mutants, the presumptive distal tip
of BA1, begin to undergo apoptosis around E9.75. The timing of
this cell death is consistent with the death associated with
reduced or absent FGF8 signaling from the pharyngeal ectoderm
in Fgf8neo/þ mutants (Abu-Issa et al., 2002). Interestingly, by this
stage of development Fgf8 expression has recovered in the
ectoderm of Foxi3 mutants (Fig. 7A). This ﬁnding suggests that
the critical period for FGF8 signaling to promote neural crest cell
survival is a window between E8.25 and 9.25 when the cells are
migrating past a region of strong FGF8 signaling into the arches. In
exploring this hypothesis via rescue experiments in zebraﬁsh
embryos, we found that induction of fgf3 expression in ectoderm
in zebraﬁsh foxi1 morphants can indeed rescue the cell death
phenotype, bypassing the need for foxi expression. Thus the
proximal cause for neural crest cell death in Foxi3 mutant mice
and foxi1mutant zebraﬁsh appears to be a transient absence of Fgf
signaling at a crucial time point during neural crest cell migration.
We propose two potential mechanisms by which Foxi3 func-
tions in relation to FGF signaling in the course of pharyngeal
development. The ﬁrst possibility is a direct genetic pathway. Foxi3
may regulate a transcriptional program that promotes Fgf8 expres-
sion. The Fgf8 regulatory region is extremely large. Loci known to
regulate speciﬁc Fgf8 expression domains have been identiﬁed
hundreds of kilobases away from the coding region, and are found
within other nearby genes (Beermann et al., 2006; Komisarczuk et
al., 2009; Marinic et al., 2013). Although no experimentally
validated binding site for mammalian Foxi3 has been identiﬁed,
the DNA binding domain of Foxi proteins is highly conserved
among homologs and across vertebrate species. Two binding site
sequences for human Foxi1, one shared with zebraﬁsh foxi1, have
been identiﬁed in a yeast experiment (Zeng et al., 2008). There are
six regions of DNA within 500 kb downstream of Fgf8 that are
conserved between chick, mouse, and human, and that contain the
predicted Foxi1 binding motif. In chick embryos, none of these
conserved sequences fused to a minimal promoter induced repor-
ter gene expression in the pharyngeal region (data not shown).
This does not rule out the possibility that FOXI3 directly regulates
Fig. 8. Patterning of truncated arches is minimally altered in Foxi3mutants. At both 15 somites and 25 somites, Pitx1 expression around BA1 is unaltered. In the Foxi3mutant
there is a reduction in Pitx1-positive cells anterior to BA1 (asterisk in Pitx1 25ss). Gsc expression remains unchanged in Foxi3 mutants (arrowheads in Goosecoid). At 25
somites, Lhx7 is found in two distinct domains in wild type embryos (arrowheads in Lhx7). Only one domain is found in Foxi3 mutant embryos at the same age (asterisk in
Lhx7). Similarly, at 25 somites in wild type embryos, Msx1 is found in two domains, whereas only one domain is present in Foxi3mutants. This pattern may represent a loss
of the distal Lhx7 and Msx1 domains, or a fusion of the two domains for each of these factors.
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Fig. 9. Fgf mis-expression in zebraﬁsh rescues the cell death phenotype in foxi1morphants. (A) and (A0) At 14 hpf (10 somites), krox20 (red) marks streams of nascent neural
crest migrating from the hindbrain whereas foxi1 (black) marks non-neural ectoderm abutting the hindbrain. No cells co-express both markers. The boxed area in (A) is
magniﬁed in (A0). Images show a dorsal view with anterior to the left. (B–I0) Embryos at later stages are oriented with anterior to the left and dorsal up, with the otic vesicle
circled with a dashed line and pharyngeal pouches marked with arrows. (B–C0) Expression of fgf3 in wild-type control embryos marks pharyngeal pouch endoderm at 22 hpf
(B) and 24 hpf (C and C0). The vertical line in (C) marks the plane of section in (C0). (D and D0) A hs:fgf3 transgenic embryo injected with foxi1-MO shows a reduced level of fgf3
expression on the non-activated side at 22 hpf (D) but shows dramatically elevated expression on the laser-activated side (D0). Note the horizontal axis in D is inverted to
facilitate comparison. Laser-activation was performed at 20 hpf, focusing on the pharyngeal region, shown in the inset to panel (D0). (E–I0) Live embryos were incubated with
acridine orange at 26 hpf to label cells undergoing apoptosis. A wild-type control embryo shows very few apoptotic cells (E) whereas a foxi1 morphant shows a marked
increase in apoptosis (F). The cell death phenotype normally seen in foxi1 morphants was strongly suppressed by global low-level activation of hs:fgf3 (37 1C for 30 min
beginning at 20 hpf) (G) or hs:fgf8 (35 1C for 6 h beginning at 20 hpf) (H). A hs:fgf3 transgenic embryo injected with foxi1-MO showed elevated apoptosis on the non-activated
side ((I) horizontal axis inverted for easier comparison), but apoptosis was strongly suppressed on the laser-irradiated side (I0).
Fig. 10. Over-expression of fgf8 or fgf3 in zebraﬁsh foxi1morphants signiﬁcantly reduces numbers of apoptotic cells in the arches. Foxi1morphants have a signiﬁcant increase
in apoptosis in the arch mesenchyme over wild type zebraﬁsh. The apoptosis phenotype can be partially rescued by global heat shock to over-express fgf8 (A) or fgf3 (B), both
under the control of heat shock promoters. fgf induction by heat shock in the absence of foxi1 knock-down does not increase cell death in the arches (A and B). The rescue
effect is speciﬁc to ectodermal fgf. Induction of fgf3 in the arch ectoderm using a low energy laser signiﬁcantly rescues cell death in the arches of foxi1morphants (C). For all
graphs, error bars represent the standard error of the mean, and tests of statistical signiﬁcance are shown by brackets. ***¼po0.05.
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Fgf8 expression, but if FOXI3 is responsible for inducing Fgf8 it may
be acting through transcriptional regulation of one or more
additional intermediate factors.
The second possibility we propose for Foxi3 function is based on
the unusual pharyngeal morphology of Foxi3 mutants; Foxi3 may be
involved in modifying epithelial morphology in the pharyngeal region,
speciﬁcally the development of pharyngeal pouches. Endoderm abla-
tion experiments in chick embryos have demonstrated that contact
with endoderm is required for the induction of Fgf8 in pharyngeal
ectoderm (Haworth et al., 2004, 2007). Thus, the failure in pouch
formation seen in Foxi3 mutants may lead to absence of ectodermal
Fgf8 and may be the underlying cause of the craniofacial defects in
these embryos. In this case, the transcriptional role of FOXI3 could be
in modulating expression of genes involved with tissue remodeling or
cell adhesion. Certainly the reﬁnement of Foxi3 expression to areas of
contact between ectoderm and endoderm would be consistent with a
function in promoting expression of adhesion factors required to
maintain pharyngeal pouch integrity under the onslaught of neural
crest cell migration. A transcriptional proﬁling experiment may be
illuminating in determining the precise transcriptional role of Foxi3 in
epithelial cells.
Whether Foxi3 acts through genetic regulation of Fgf8, through
regulation of tissue remodeling and adhesion factors, or through
some other mechanism, it is clearly of critical importance to
pharyngeal development. Further exploration of the genetic path-
ways in which FOXI3 is integrated could open the way to better
understanding of signaling pathways in the pharyngeal region and
the conserved morphogenetic processes responsible for generat-
ing one deﬁning factor of the vertebrate morphology – the
branchial arches.
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